SVI
KANG

Strategic Vision Investment’s iKang Healthcare Group, Inc. KANG Stock Holding History

Strategic Vision Investment’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-156,459
Closed -$2.47M – 14
2017
Q4 		$2.47M Buy
+156,459
New +$2.26M 2.51% 10

Other funds holding KANG

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Strategic Vision Investment's KANG Position: Q1 2018 in Review

Strategic Vision Investment sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2018, closing a stake of 156,459 shares — an estimated $2.47M sold.

Strategic Vision Investment first reported a position in KANG in Q4 2017 and held it in 1 quarter. The position peaked at $2.47M in Q4 2017. 60 funds tracked by Wall St. Rank hold KANG as of Q1 2018.

  • Strategic Vision Investment reported no remaining iKang Healthcare Group, Inc. position as of Q1 2018 after selling out during the quarter.
  • Strategic Vision Investment sold 156,459 iKang Healthcare Group, Inc. shares in Q1 2018, an estimated $2.47M.
  • Strategic Vision Investment first reported a position in iKang Healthcare Group, Inc. in Q4 2017 and held it in 1 quarter.
  • Strategic Vision Investment's iKang Healthcare Group, Inc. position peaked at $2.47M in Q4 2017.
  • 60 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2018.

Based on Strategic Vision Investment's 13F filing for Q1 2018, filed 15 May 2018.